July 25 (Reuters) - Teva Pharmaceutical Industries (NYSE:TEVA) Ltd TEVA.TA
* Teva canada innovation announces approval of cinqair by health canada
* Treatment is expected to become commercially available to patients, by prescription, in late fall 2016
* Upon commercial availability of cinqair, teva canada innovation will launch teva support solutions in canada Source text for Eikon: ID:nCNWnms22a Further company coverage: TEVA.TA
(Bengaluru Newsroom: +1-646-223-8780)